Forecast of the Day: Philip Morris International

by Trefis Team
+23.65%
Upside
88.68
Market
110
Trefis
PM
Philip Morris International
Rate   |   votes   |   Share

FDA has approved Philip Morris International’s (NYSE: PM) IQOS 3 system. The product is authorized by the agency for sale in the U.S. The FDA’s decision follows an assessment of a premarket tobacco product application filed with the agency in March 2020.

Click here for the full Trefis coverage of Philip Morris International

Looking for a balanced portfolio to invest in? Here’s a high-quality portfolio to beat the market, with over 100% return since 2016, versus 55% for the S&P 500. Comprised of companies with strong revenue growth, healthy profits, lots of cash, and low risk, it has outperformed the broader market year after year, consistently.

 

See all Trefis Price Estimates and Download Trefis Data here

What’s behind Trefis? See How It’s Powering New Collaboration and What-Ifs For CFOs and Finance Teams | Product, R&D, and Marketing Teams

 

Rate   |   votes   |   Share

Comments

Name (Required)
Email (Required, but never displayed)
Be the first to comment!